Targovax Receives 2017 Nordic Stars Award
Targovax Receives 2017 Nordic Stars Award Oslo, Norway, 14 September 2017: Targovax ASA (“Targovax” or “the Company”; OSE: TRVX), a clinical stage company focused on developing immuno-oncology therapies to target solid tumors, today announces that they are one of three companies to have been selected for this year’s Nordic Stars Awards, presented by SwedenBIO. This […]
biopharmaceutical company focused in the structure-based drug discovery and development of novel therapeutics in unmet medical need areas of inflammation, oncology, and infectious disease.
Aptose Biosicences and CrystalGenomics Announce Issuance of U.S. Patent for CG’806 SAN DIEGO and TORONTO and SEOUL, South Korea, Sept. 12, 2017 (GLOBE NEWSWIRE) — Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ:APTO) (TSX:APS), a clinical-stage company developing highly differentiated therapeutics targeting the underlying mechanisms of cancer, today announced that the United States Patent and […]
Chronic Pain Management Without the Use of Opioids to Help People Avoid Back and Neck Surgery
Chronic pain can be defined medically as pain lasting for more than three months. The severity of the pain may vary depending on the etiology. Chronic pain can occur as a result of tissue damage or neuro-psychic issues. The etiology could arise from the body or any part of the central nervous system. It could be treated with opioids, nonopioids, and psychotherapy (cognitive behavior therapy and commitment therapy). The treatment can be influenced by on the etiology of the disease